保留脾胰体尾在近端胃癌根治术中临床观察与分析

Clinical observation and analysis of reservating the spleen pancreatic body and tail in proximal gastric cancer radical operation

目的探讨近端胃癌根治术中保留脾胰体尾，清除第10、11组淋巴结的可行性。方法分析56例保留脾胰体尾近端胃癌根治术的手术及愈后情况。结果本组中56例第10组淋巴结转移率为20％（11／56），第11组淋巴结转移率为18％（9／56）。5年生存率为48％，10年生存率为20％。并发症发生率7％。结论保留脾胰体尾近端胃癌根治术5年，10年生存率与切除脾胰体尾差异无统计学意义。术后并发症发生率明显低于传统的切除脾胰体尾根治术。

Objective To investigate feasibility of reservating the spleen pancreatic body and tail in the proximal gastric cancer radical resection, removing No. 10, No. 11 group lymph nodes . Methods Fify - six cases of the proximal gastric cancer radical operation reserved spleen pancreatic body and tail and prognosis were analyzed. Results In the 56 cases, No. 10 group lymph node metastasis was 20% （ 11/56）, No. 11 group lymph node metastasis rate was 18% （9/56）. 5 -year survival rate was 48% , 10 -year survival rate was 20%. Complication rate was 7%. Conclusion Compared with resection of spleen pancreatic body and tail, five years, 10 - year survival rate of reservating spleen pancreatic body and tail in the proximal gastric cancer radical operation were no significant difference, but postoperative complication rate was significantly lower than traditional spleen resection of pancreatic tail radical operation.